Trial · NCT00912093
Adverse events48
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 48
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase - Icatibant (Randomized) | 5 | 46 | 5 |
| other | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase -Placebo (Randomized) | 9 | 46 | 9 |
| other | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase - Icatibant (Open Label) | 0 | 6 | 0 |
| other | Hereditary angioedema | Congenital, familial and genetic disorders | Open Label Extension - Icatibant (Open Label) | 11 | 82 | 17 |
| other | Headache | Nervous system disorders | Controlled Phase - Icatibant (Randomized) | 3 | 46 | 4 |
| other | Headache | Nervous system disorders | Controlled Phase -Placebo (Randomized) | 3 | 46 | 3 |
| other | Headache | Nervous system disorders | Controlled Phase - Icatibant (Open Label) | 0 | 6 | 0 |
| other | Headache | Nervous system disorders | Open Label Extension - Icatibant (Open Label) | 9 | 82 | 12 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Controlled Phase - Icatibant (Randomized) | 0 | 46 | 0 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Controlled Phase -Placebo (Randomized) | 0 | 46 | 0 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Controlled Phase - Icatibant (Open Label) | 0 | 6 | 0 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Open Label Extension - Icatibant (Open Label) | 5 | 82 | 7 |
| serious | Myocardial infarction | Cardiac disorders | Controlled Phase - Icatibant (Randomized) | 0 | 46 | 0 |
| serious | Myocardial infarction | Cardiac disorders | Controlled Phase -Placebo (Randomized) | 1 | 46 | 1 |
| serious | Myocardial infarction | Cardiac disorders | Controlled Phase - Icatibant (Open Label) | 0 | 6 | 0 |
| serious | Myocardial infarction | Cardiac disorders | Open Label Extension - Icatibant (Open Label) | 0 | 82 | 0 |
| serious | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase - Icatibant (Randomized) | 0 | 46 | 0 |
| serious | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase -Placebo (Randomized) | 2 | 46 | 2 |
| serious | Hereditary angioedema | Congenital, familial and genetic disorders | Controlled Phase - Icatibant (Open Label) | 0 | 6 | 0 |
| serious | Hereditary angioedema | Congenital, familial and genetic disorders | Open Label Extension - Icatibant (Open Label) | 3 | 82 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00912093/events